UPenn
Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging
The panel's developers at UPenn hope to validate and commercialize a non-invasive assay through a startup called Chip Diagnostics.
Nearly 3,500 patients were referred to the Roberts Individualized Medical Genetics Center for exome sequencing or other testing during the clinical program's first four years.
UPenn researchers believe that their lateral flow assay has the potential to be the first point-of-care test that can detect fentanyl and its metabolite, norfentanyl, at clinically relevant cutoffs.
UPenn Targeting Ultrasensitive Protein Detection at the POC With Microbubbling Digital Assay
Premium
A UPenn research team has developed a proof-of-principle detection platform that uses microbubbles to make target protein molecules visible and detectable.
Wistar Institute Spinout Isoma Diagnostics Secures Seed Funding
Isoma, which launched last year, will use the funds to develop and clinically validate a molecular test for stratifying glioblastoma patients.